SANGAMO THERAPEUTICS INC COM USD0.01 earnings per share and revenue

0R1D earnings per share for the last quarter are 0.04 USD whereas the estimation was -0.02 USD which accounts for 362.30% surprise. Company revenue for the same period amounts to 49.40 M USD despite the estimated figure of 20.92 M USD. Estimated earnings per share for the next quarter are -0.09 USD, and revenue is expected to reach 10.38 M USD. Also watch annual changes over time to get a bigger picture of 0R1D earnings per share and revenue dynamics.